Showing results (111-120 of 136) with videos related to
Sort By:
Pageof 14
Clinical Pharmacology and Therapeutics|August 4, 2004
Human sympathetic activation by alpha2-adrenergic blockade with yohimbine: Bimodal, epistatic influence of cytochrome P450-mediated drug metabolismPascal Le Corre, Robert J Parmer, Mala T Kailasam, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 20, 2005
Pharmacogenetics of tamoxifen biotransformation is associated with clinical outcomes of efficacy and hot flashesMatthew P Goetz, James M Rae, Vera J Suman, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 2008
Association of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 genetic polymorphisms with outcome in a trial of paclitaxel compared with paclitaxel plus bevacizumab in advanced breast cancer: ECOG 2100Bryan P Schneider, Molin Wang, Milan Radovich, et al.Human Molecular Genetics|December 20, 2011
A genome-wide association study identifies locus at 10q22 associated with clinical outcomes of adjuvant tamoxifen therapy for breast cancer patients in JapaneseKazuma Kiyotani, Taisei Mushiroda, Tatsuhiko Tsunoda, et al.Steroids|August 28, 2014
Estrogens and their precursors in postmenopausal women with early breast cancer receiving anastrozoleJames N Ingle, Krishna R Kalari, Aman U Buzdar, et al.Breast Cancer Research and Treatment|April 3, 2013
Genetic associations with toxicity-related discontinuation of aromatase inhibitor therapy for breast cancerN Lynn Henry, Todd C Skaar, Jessica Dantzer, et al.Cancer Research|April 1, 2010
Variation in anastrozole metabolism and pharmacodynamics in women with early breast cancerJames N Ingle, Aman U Buzdar, Daniel J Schaid, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 4, 2010
Significant effect of polymorphisms in CYP2D6 and ABCC2 on clinical outcomes of adjuvant tamoxifen therapy for breast cancer patientsKazuma Kiyotani, Taisei Mushiroda, Chiyo K Imamura, et al.The Oncologist|March 25, 2016
Patient-Reported Outcomes and Early Discontinuation in Aromatase Inhibitor-Treated Postmenopausal Women With Early Stage Breast CancerKunal C Kadakia, Claire F Snyder, Kelley M Kidwell, et al.Annals of Internal Medicine|November 23, 2006
Pharmacogenomics: challenges and opportunitiesDan M Roden, Russ B Altman, Neal L Benowitz, et al.Pageof 14